Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Cirrhosis severity and CD4 cell counts were linked to a greater chance of developing liver cancer.
People treated with direct-acting antivirals had better overall survival than those whose hepatitis C remained untreated.
Barriers still stand in the way of making treatment available to all who need it.
Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.
Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.
Study results underline the importance of treating hepatitis C virus.
Successful treatment with direct-acting antivirals prolonged survival by 18 months.
Those diagnosed with liver cancer after an HCV cure had a 66% lower risk of death.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
The VA has cured HCV in nearly 100,000 veterans, which will dramatically reduce the development of advanced liver disease and liver cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.